Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States
Wang K, Qian D, Hu Y, Cheng Y, Ge S, Yao Y
American journal of nephrology · 15 citas
Etiquetas de revisión
Sin ajuste declarado por estilo de vidaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio de cohortes (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2022-01-01 · Am J Nephrol · vol. 53 · número 6 · págs. 503–512
- Editorial
- Karger Publishers
- Citado
- 17 citas · más que el 80% de estudios similares · 1.5× el promedio de su campo
- Referencias
- 55 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY-NC
- Áreas de investigación
- Nuts composition and effects · Botany, Ecology, and Taxonomy Studies · Oral Health Pathology and Treatment
- Palabras clave
- Medicine, Kidney disease, Hazard ratio, Confidence interval, Proportional hazards model, Population, Logistic regression, Internal medicine, Nut, Demography, Environmental health
- MeSH
- humans, nuts, cardiovascular diseases, diet, nutrition surveys, risk factors, prospective studies, adult, united states, renal insufficiency, chronic
6 autores
- Koushu Wang🇨🇳Tongji Hospital; Huazhong University of Science and Technology
- Duo Qian🇨🇳Tongji Hospital; Huazhong University of Science and Technology
- Yuncan Hu🇨🇳Tongji Hospital; Huazhong University of Science and Technology
- Yichun Cheng🇨🇳Tongji Hospital; Huazhong University of Science and Technology
- Shuwang Ge🇨🇳Tongji Hospital; Huazhong University of Science and Technology
- Ying Yao🇨🇳Tongji Hospital; Huazhong University of Science and Technology
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Nuts have been found to have beneficial effects on some diseases, including cardiovascular disease and cancer, in several studies. However, there are few studies to show the effects of nuts on chronic kidney disease (CKD). Thus, we conducted this study to examine the association between the consumption frequency of nuts and the prevalence and mortality of CKD among adults in the USA.
Methods
We analyzed data from 6,072 individuals (aged ≥20 years) who participated in the NHANES 2003-2006 following the scheduled procedure. Data on death were provided by the CDC. A logistic regression model was used to evaluate the association between nut consumption frequency and the prevalence of CKD. A Cox proportional hazards regression model was performed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between nut consumption frequency and all-cause mortality and cardiovascular mortality in the CKD and non-CKD populations.
Results
Consuming nuts 1-6 times per week was associated with a lower prevalence of CKD (model 3: OR: 0.67; 95% CI: 0.49-0.91). In addition, higher nut consumption was significantly associated with lower all-cause and cardiovascular mortality in the non-CKD population. For the CKD population, a consistently significant inverse association could be seen between consuming nuts 1-6 per week and all-cause mortality (model 3: HR: 0.63; 95% CI: 0.47-0.86). No groups showed a significant difference in cardiovascular mortality compared with the reference in the full model.
Conclusion
We recommend the CKD population to have an adequate intake of nuts 1-6 times per week, while the consumption frequency can be more flexible for the non-CKD. Further prospective studies should be conducted to confirm this conclusion.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.